Compare AU
Compare CETF vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the FTSE China Top 50 (CETF) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
CETF | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 30 | 241 |
Median incremental investment | $956.32 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,338.83 | $1,668.48 |
Average age group | > 35 | 26 - 35 |
Key Summary
CETF | IXJ | |
|---|---|---|
Strategy | CETF.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund seeks to provide investors with access to a portfolio of the 50 largest companies in the mainland Chinese market. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | Kweichow Moutai Co Ltd Class A (11.64 %) Contemporary Amperex Technology Co Ltd Class A (7.23 %) China Merchants Bank Co Ltd Class A (4.76 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Financials (35.50 %) Consumer Staples (33.17 %) Industrials (15.44 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | China (100.00 %) | United States (99.97 %) |
Management fee | 0.6 % | 0.46 % |
Key Summary
CETF | IXJ | |
|---|---|---|
Issuer | VanEck | iShares |
Tracking index | FTSE China A50 Index - CNY | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.6 % | 0.46 % |
Price | $58.21 | $139.04 |
Size | $34.649 million | $1.380 billion |
10Y return | N/A | 126.43 % |
Annual distribution yield (5Y) | 2.02 % | 1.26 % |
Market | ASX | ASX |
First listed date | 26/06/2015 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
CETF | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 30 | 241 |
Median incremental investment | $956.32 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,338.83 | $1,668.48 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
CETF | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
CETF | IXJ |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |